Importance The article investigates the issue of evaluating R&D results in accounting and financial reporting. Whereas regulatory documents fail to set forth unambiguous standards, it is very important for entities to measure these items. Objectives The research scrutinizes various reasons for determining the most appropriate method to measure R&D results for accounting purposes and disclose them respectively in financial statements. Methods Analyzing and comparing requirements of regulatory documents, I unveil approaches to measuring R&D that exist in accounting practices, and prospects of such measurements. Results I substantiate the need to apply a common approach to corporate assets measurement by improving the regulatory system of rates and generating reliable information on R&D results. Conclusions and Relevance I conclude that in the current circumstances R&D results should be assessed by total costs incurred to perform those R&D before laws-makers find a solution to regulatory improvements that would set up uniform approaches to recognition of various items for accounting purposes. Capitalization of costs is considered a promising option at the R&D stage only, which will be very frequent due to changing regulatory requirements. The article will prove useful for accounting specialists in taking more reasonable decisions on a certain approach to R&D measurements.